Driehaus Capital Management announces with deep sadness the unexpected passing of its Founder, Richard H. Driehaus, of natural causes at the age of 78.
“Richard led a life of zest and intellectual curiosity. His path and personal story were larger than life, and the impact he made as an investor is perhaps only rivaled by the extensive legacy he left as a philanthropist,” said Driehaus President and CEO Steve Weber.Read more
Driehaus Capital Management is an independent boutique investment adviser managing long-only equity and multi-asset alternative strategies.
of institutional investment experience, founded in 1982 by renowned investor Richard H. Driehaus.
At Driehaus, we believe life sciences innovation has set the backdrop for extensive improvement in human health and explosive opportunities for value creation. The clustered regularly interspaced short palindromic repeats (CRISPR/Cas9)-based gene editing technology is earlier in its life cycle but may be a potential disruptor.
Secular growth and work-from-home assets outperformed in 2020 as the world struggled with the initial onset of Covid-19. In the first quarter of 2021 cyclical and value assets rebounded as vaccines were rolled out and the world emerged from lockdown. That quickly led to myriad reports of inflation, with concerns amplified by the Fed’s stated willingness to let the economy run hot.